Position in NSPR
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$2,588,854
-$2,583,729 QoQ
Shares Held
3,698,364
+16.5% QoQ
Ownership
7.96%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 37 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSPR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $874,120,974 across 19 Medical Devices names. NSPR ranks #17 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
2,990,059 | $233,912,315 | |
| 2 | ABT |
Abbott Laboratories
|
2,183,521 | $198,132,694 | |
| 3 | BSX |
Boston Scientific Corp
|
3,066,626 | $130,883,596 | |
| 4 | SYK |
Stryker Corp
|
306,201 | $96,404,322 | |
| 5 | EW |
Edwards Lifesciences Corp
|
497,362 | $44,991,365 | |
| 6 | PODD |
Insulet Corp
|
287,840 | $43,823,638 | |
| 7 | DXCM |
Dexcom Inc
|
456,802 | $30,765,613 | |
| 8 | STE |
STERIS plc
|
84,877 | $17,872,549 |
All Filings in NSPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,588,854 | 3,698,364 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $5,172,583 | 3,173,364 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $5,648,587 | 3,173,364 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $5,979,491 | 2,481,117 | Shares | Defined | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||